Bayer stock: UBS keeps EUR 62.00 target for Bayer stock

Published on 10/19/2026 at 15:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bayer reports third-quarter results on November 3, 2026. Bayer stock costs EUR 43.46 on October 19, 2026, down 2.25 percent versus the Xetra close.

Analyst view and reporting date

The October 18, 2026 UBS note retained a EUR 62.00 target for Bayer.
Bayer's third-quarter results are scheduled for November 3, 2026.
Bayer stock costs EUR 43.46 at Lang & Schwarz on October 19, 2026 at 3:10 p.m. CEST, 2.25 percent below the Xetra close of October 16, 2026 at EUR 44.46.
Bayer's market capitalization is EUR 42.7 billion as of October 19, 2026.

Schwarzweiß-Dokumentarfoto einer großen Chemieanlage am Flussufer mit Rohrleitungen und Türmen — Bayer AG (DE000BAY0017): dokumentarische Schwarzweiß-Reportage-Aufnahme einer großen Chemiefabrik am Rheinufer mit hohen Türmen, Illustration mit AI erstellt.

UBS kept its Buy rating and EUR 62.00 target for Bayer on October 18, 2026, according to 4investors, putting the target 42.66 percent above the current price. At Lang & Schwarz, Bayer traded at EUR 43.46 on October 19, 2026 at 3:10 p.m. CEST, down 2.25 percent versus the Xetra close of October 16, 2026 (EUR 44.46).

November results set the next test

Bayer's next scheduled reporting date is November 3, 2026. The company will publish third-quarter results at 7:30 a.m. CET and hold its investor conference at 2:00 p.m. CET, according to Bayer. The calendar gives the stock a defined next checkpoint after the current analyst support.

52-week range and market value

The EUR 43.46 price sits 19.41 percent below Bayer's 52-week high of EUR 53.92 and 68.58 percent above its low of EUR 25.78. Both levels and the October 19, 2026 market value come from the same quoted range, keeping the price position tied to one period. Bayer's market capitalization is EUR 42.7 billion as of October 19, 2026, while the session volume stood at 587,323 shares.

Valuation stays tied to targets

The UBS target of EUR 62.00 is 42.66 percent above the Lang & Schwarz price. JPMorgan also retained a positive view with a EUR 61.00 target, according to 4investors on October 18, 2026. The two targets place the analyst discussion well above the current quotation, while Bayer's next results will provide the next company-specific test.

Comparison with peers

Bayer: minus 2.25 percent, market capitalization EUR 42.7 billion

BASF (Xetra, EUR): minus 1.60 percent, P/E 7.88, market capitalization EUR 45.2 billion

Merck KGaA (Xetra, EUR): minus 1.52 percent, P/E 26.07, market capitalization EUR 61.8 billion

Trading position for investors

Bayer's current price is below its 52-week high, while the analyst targets remain dated reference points ahead of the November results. The combination of a 2.25 percent daily decline and the 19.41 percent distance from the yearly high makes the scheduled report the next concrete date for the stock.

At Lang & Schwarz, Bayer was trading at EUR 43.46 on October 19, 2026 at 3:10 p.m. CEST, 2.25 percent below the Xetra close of October 16, 2026 at EUR 44.46. The further course of trading is shown by the continuously updated real-time quote of Bayer stock.